Flu shot study seeks clues in HIV and aging
NCT ID NCT04487041
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study looks at blood samples from 400 people with and without HIV to understand how aging and HIV infection change the body's immune response to the flu vaccine. Researchers will measure antibody levels and immune cell types to see who responds well to the vaccine and who does not. The goal is to learn more, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Miami
Miami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune-Boosting cocktail aims to free HIV patients from daily medication
- Pee test could revolutionize HIV treatment adherence
- Could sharing your HIV status help you stick to medication?
- Could one pill a day make HIV treatment easier? a new study asks patients
- Electronic monitors reveal HIV medication habits in pregnancy and beyond
- Giving people a choice in HIV care may boost treatment uptake after jail